Whether the pharmaceuticals industries be permitted to manufacture antiretroviral drugs (ARVs) at low cost in order to sell in needy countries or not. Introduction: The ARV drugs are used against the treatment of AIDS (acquired immunodeficiency syndrome). These drugs are very expensive and are still in the phase of research for developing better varieties. The monthly cost of these drugs is almost $2500, which makes them accessible to the underdeveloped countries like Africa.

Question

Want to see more full solutions like this?

Answer 1

Question

Chapter 9, Problem 1QC

Summary Introduction

To review:

Whether the pharmaceuticals industries be permitted to manufacture antiretroviral drugs (ARVs) at low cost in order to sell in needy countries or not.

Introduction:

The ARV drugs are used against the treatment of AIDS (acquired immunodeficiency syndrome). These drugs are very expensive and are still in the phase of research for developing better varieties. The monthly cost of these drugs is almost $2500, which makes them accessible to the underdeveloped countries like Africa.

Expert Solution & Answer

Explanation of Solution

Africa holds more than half of the world’s population of people who are affected by HIV (Human immunodeficiency virus). These people cannot afford to the treatment methods imparted for AIDS. The pharmaceuticals of United States (US) are taking up the R&D (research and development) for the ARV drugs.

However, the cost of research and final drug is so high that it is unable to be afforded by the poor people. As a result of this, the pharmaceutical firms of countries other than the US are manufacturing these drugs at a much cheaper price and supplying in needy countries. The price is cheap because they do not have to spend on research, unlike the US pharmaceuticals. This decision or act might appear worthy of appreciation but it also poses a risk to the ongoing research that aims to develop superior and effective variety of these drugs.

Research takes time and these countries cannot wait for so long. So, the best solution can be to impose a check on the export of these drugs and should be restricted to the neediest countries like Africa. On the US’s part, the government should speed up the R&D projects to meet the demands of these drugs.

Conclusion

Thus, it can be concluded that the foreign countries should not be allowed to produce and export the ARVs uncontrollably. In case, immediate help is required, the drugs made by them can be supplied to poor countries.

Want to see more full solutions like this?

Subscribe now to access step-by-step solutions to millions of textbook problems written by subject matter experts!

Students have asked these similar questions

Biology Question

✓ Details Draw a protein that is embedded in a membrane (a transmembrane protein), label the lipid bilayer and the protein. Identify the areas of the lipid bilayer that are hydrophobic and hydrophilic. Draw a membrane with two transporters: a proton pump transporter that uses ATP to generate a proton gradient, and a second transporter that moves glucose by secondary active transport (cartoon-like is ok). It will be important to show protons moving in the correct direction, and that the transporter that is powered by secondary active transport is logically related to the proton pump.

drawing chemical structure of ATP. please draw in and label whats asked. Thank you.

Answer 2

Question

Chapter 9, Problem 1QC

Summary Introduction

To review:

Whether the pharmaceuticals industries be permitted to manufacture antiretroviral drugs (ARVs) at low cost in order to sell in needy countries or not.

Introduction:

The ARV drugs are used against the treatment of AIDS (acquired immunodeficiency syndrome). These drugs are very expensive and are still in the phase of research for developing better varieties. The monthly cost of these drugs is almost $2500, which makes them accessible to the underdeveloped countries like Africa.

Expert Solution & Answer

Explanation of Solution

Africa holds more than half of the world’s population of people who are affected by HIV (Human immunodeficiency virus). These people cannot afford to the treatment methods imparted for AIDS. The pharmaceuticals of United States (US) are taking up the R&D (research and development) for the ARV drugs.

However, the cost of research and final drug is so high that it is unable to be afforded by the poor people. As a result of this, the pharmaceutical firms of countries other than the US are manufacturing these drugs at a much cheaper price and supplying in needy countries. The price is cheap because they do not have to spend on research, unlike the US pharmaceuticals. This decision or act might appear worthy of appreciation but it also poses a risk to the ongoing research that aims to develop superior and effective variety of these drugs.

Research takes time and these countries cannot wait for so long. So, the best solution can be to impose a check on the export of these drugs and should be restricted to the neediest countries like Africa. On the US’s part, the government should speed up the R&D projects to meet the demands of these drugs.

Conclusion

Thus, it can be concluded that the foreign countries should not be allowed to produce and export the ARVs uncontrollably. In case, immediate help is required, the drugs made by them can be supplied to poor countries.

Want to see more full solutions like this?

Subscribe now to access step-by-step solutions to millions of textbook problems written by subject matter experts!

Answer 3

Question

Chapter 9, Problem 1QC

Summary Introduction

To review:

Whether the pharmaceuticals industries be permitted to manufacture antiretroviral drugs (ARVs) at low cost in order to sell in needy countries or not.

Introduction:

The ARV drugs are used against the treatment of AIDS (acquired immunodeficiency syndrome). These drugs are very expensive and are still in the phase of research for developing better varieties. The monthly cost of these drugs is almost $2500, which makes them accessible to the underdeveloped countries like Africa.

Expert Solution & Answer

Explanation of Solution

Africa holds more than half of the world’s population of people who are affected by HIV (Human immunodeficiency virus). These people cannot afford to the treatment methods imparted for AIDS. The pharmaceuticals of United States (US) are taking up the R&D (research and development) for the ARV drugs.

However, the cost of research and final drug is so high that it is unable to be afforded by the poor people. As a result of this, the pharmaceutical firms of countries other than the US are manufacturing these drugs at a much cheaper price and supplying in needy countries. The price is cheap because they do not have to spend on research, unlike the US pharmaceuticals. This decision or act might appear worthy of appreciation but it also poses a risk to the ongoing research that aims to develop superior and effective variety of these drugs.

Research takes time and these countries cannot wait for so long. So, the best solution can be to impose a check on the export of these drugs and should be restricted to the neediest countries like Africa. On the US’s part, the government should speed up the R&D projects to meet the demands of these drugs.

Conclusion

Thus, it can be concluded that the foreign countries should not be allowed to produce and export the ARVs uncontrollably. In case, immediate help is required, the drugs made by them can be supplied to poor countries.

Want to see more full solutions like this?

Subscribe now to access step-by-step solutions to millions of textbook problems written by subject matter experts!

Answer 4

Question

Chapter 9, Problem 1QC

Summary Introduction

To review:

Whether the pharmaceuticals industries be permitted to manufacture antiretroviral drugs (ARVs) at low cost in order to sell in needy countries or not.

Introduction:

The ARV drugs are used against the treatment of AIDS (acquired immunodeficiency syndrome). These drugs are very expensive and are still in the phase of research for developing better varieties. The monthly cost of these drugs is almost $2500, which makes them accessible to the underdeveloped countries like Africa.

Expert Solution & Answer

Explanation of Solution

Africa holds more than half of the world’s population of people who are affected by HIV (Human immunodeficiency virus). These people cannot afford to the treatment methods imparted for AIDS. The pharmaceuticals of United States (US) are taking up the R&D (research and development) for the ARV drugs.

However, the cost of research and final drug is so high that it is unable to be afforded by the poor people. As a result of this, the pharmaceutical firms of countries other than the US are manufacturing these drugs at a much cheaper price and supplying in needy countries. The price is cheap because they do not have to spend on research, unlike the US pharmaceuticals. This decision or act might appear worthy of appreciation but it also poses a risk to the ongoing research that aims to develop superior and effective variety of these drugs.

Research takes time and these countries cannot wait for so long. So, the best solution can be to impose a check on the export of these drugs and should be restricted to the neediest countries like Africa. On the US’s part, the government should speed up the R&D projects to meet the demands of these drugs.

Conclusion

Thus, it can be concluded that the foreign countries should not be allowed to produce and export the ARVs uncontrollably. In case, immediate help is required, the drugs made by them can be supplied to poor countries.

Want to see more full solutions like this?

Subscribe now to access step-by-step solutions to millions of textbook problems written by subject matter experts!

Answer 5

Chapter 9, Problem 1QC

Summary Introduction

To review:

Whether the pharmaceuticals industries be permitted to manufacture antiretroviral drugs (ARVs) at low cost in order to sell in needy countries or not.

Introduction:

The ARV drugs are used against the treatment of AIDS (acquired immunodeficiency syndrome). These drugs are very expensive and are still in the phase of research for developing better varieties. The monthly cost of these drugs is almost $2500, which makes them accessible to the underdeveloped countries like Africa.

Expert Solution & Answer

Explanation of Solution

Africa holds more than half of the world’s population of people who are affected by HIV (Human immunodeficiency virus). These people cannot afford to the treatment methods imparted for AIDS. The pharmaceuticals of United States (US) are taking up the R&D (research and development) for the ARV drugs.

However, the cost of research and final drug is so high that it is unable to be afforded by the poor people. As a result of this, the pharmaceutical firms of countries other than the US are manufacturing these drugs at a much cheaper price and supplying in needy countries. The price is cheap because they do not have to spend on research, unlike the US pharmaceuticals. This decision or act might appear worthy of appreciation but it also poses a risk to the ongoing research that aims to develop superior and effective variety of these drugs.

Research takes time and these countries cannot wait for so long. So, the best solution can be to impose a check on the export of these drugs and should be restricted to the neediest countries like Africa. On the US’s part, the government should speed up the R&D projects to meet the demands of these drugs.

Conclusion

Thus, it can be concluded that the foreign countries should not be allowed to produce and export the ARVs uncontrollably. In case, immediate help is required, the drugs made by them can be supplied to poor countries.

Answer 6

Chapter 9, Problem 1QC

Summary Introduction

To review:

Whether the pharmaceuticals industries be permitted to manufacture antiretroviral drugs (ARVs) at low cost in order to sell in needy countries or not.

Introduction:

The ARV drugs are used against the treatment of AIDS (acquired immunodeficiency syndrome). These drugs are very expensive and are still in the phase of research for developing better varieties. The monthly cost of these drugs is almost $2500, which makes them accessible to the underdeveloped countries like Africa.

Expert Solution & Answer

Explanation of Solution

Africa holds more than half of the world’s population of people who are affected by HIV (Human immunodeficiency virus). These people cannot afford to the treatment methods imparted for AIDS. The pharmaceuticals of United States (US) are taking up the R&D (research and development) for the ARV drugs.

However, the cost of research and final drug is so high that it is unable to be afforded by the poor people. As a result of this, the pharmaceutical firms of countries other than the US are manufacturing these drugs at a much cheaper price and supplying in needy countries. The price is cheap because they do not have to spend on research, unlike the US pharmaceuticals. This decision or act might appear worthy of appreciation but it also poses a risk to the ongoing research that aims to develop superior and effective variety of these drugs.

Research takes time and these countries cannot wait for so long. So, the best solution can be to impose a check on the export of these drugs and should be restricted to the neediest countries like Africa. On the US’s part, the government should speed up the R&D projects to meet the demands of these drugs.

Conclusion

Thus, it can be concluded that the foreign countries should not be allowed to produce and export the ARVs uncontrollably. In case, immediate help is required, the drugs made by them can be supplied to poor countries.

Answer 7

Chapter 9, Problem 1QC

Summary Introduction

To review:

Whether the pharmaceuticals industries be permitted to manufacture antiretroviral drugs (ARVs) at low cost in order to sell in needy countries or not.

Introduction:

The ARV drugs are used against the treatment of AIDS (acquired immunodeficiency syndrome). These drugs are very expensive and are still in the phase of research for developing better varieties. The monthly cost of these drugs is almost $2500, which makes them accessible to the underdeveloped countries like Africa.

Answer 8

Expert Solution & Answer

Explanation of Solution

Africa holds more than half of the world’s population of people who are affected by HIV (Human immunodeficiency virus). These people cannot afford to the treatment methods imparted for AIDS. The pharmaceuticals of United States (US) are taking up the R&D (research and development) for the ARV drugs.

However, the cost of research and final drug is so high that it is unable to be afforded by the poor people. As a result of this, the pharmaceutical firms of countries other than the US are manufacturing these drugs at a much cheaper price and supplying in needy countries. The price is cheap because they do not have to spend on research, unlike the US pharmaceuticals. This decision or act might appear worthy of appreciation but it also poses a risk to the ongoing research that aims to develop superior and effective variety of these drugs.

Research takes time and these countries cannot wait for so long. So, the best solution can be to impose a check on the export of these drugs and should be restricted to the neediest countries like Africa. On the US’s part, the government should speed up the R&D projects to meet the demands of these drugs.

Answer 9

Expert Solution & Answer

Answer 10

Expert Solution & Answer

Answer 11

Conclusion

Thus, it can be concluded that the foreign countries should not be allowed to produce and export the ARVs uncontrollably. In case, immediate help is required, the drugs made by them can be supplied to poor countries.

Answer 12

Ch. 9 - Prob. 1QC Ch. 9 - Prob. 2QC Ch. 9 - Define the term pathogen and give some examples.Ch. 9 - Prob. 2CR Ch. 9 - Prob. 3CR Ch. 9 - Prob. 4CR Ch. 9 - Prob. 5CR Ch. 9 - Describe in general terms the distinction between...Ch. 9 - Describe the concept of an antigen and how it...Ch. 9 - Prob. 8CR

Videos

Explanation of Solution

Want to see more full solutions like this?

Chapter 9 Solutions